Impacto de la fragilidad y la carga viral en la lesión renal aguda en los pacientes afectados por Covid-19
| datacite.rights | http://purl.org/coar/access_right/c_16ec | spa |
| dc.contributor.advisor | Aroca Martinez, Gustavo | |
| dc.contributor.advisor | Musso, Carlos G. | |
| dc.contributor.author | Avendaño Echávez, Lil Geraldine | |
| dc.date.accessioned | 2022-01-31T14:14:36Z | |
| dc.date.available | 2022-01-31T14:14:36Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | El COVID-19 puede afectar muchos otros órganos además del sistema respiratorio, particularmente en el riñón, el corazón, el tracto digestivo, la sangre y el sistema nervioso. En cuanto a las alteraciones renales, los informes preliminares indicaron una incidencia del 3% al 9% y cada vez hay más pruebas de que la lesión renal aguda (IRA) es frecuente en la infección por SARS-CoV-2, con una incidencia informada de 8-17%, llegando al 35% en pacientes críticos, y que esta condición se considera un factor de mal pronóstico. En este sentido, el desarrollo de IRA en el contexto de la COVID-19 tiene una mortalidad asociada del 91,7%. | spa |
| dc.description.abstract | COVID-19 can affect many other organs in addition to the respiratory system, particularly in the kidney, heart , digestive tract, blood, and nervous system. As for the kidney altera t ions , preliminary reports indicated an incidence of 3%–9% and there is growing evidenc e that acute kidney injury (AKI) is prevalent in SARSCoV-2 infection, with a repor t ed incidenc e of 8%–17%, reaching 35% in critical patients , and that this condition is considered a poor prognostic factor. In this sense, the development of AKI in the context of COVID-19 has an associated mortality of 91.7%. | spa |
| dc.format.mimetype | spa | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/9329 | |
| dc.language.iso | spa | spa |
| dc.publisher | Ediciones Universidad Simón Bolívar | spa |
| dc.publisher | Facultad de Ciencias de la Salud | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.accessrights | info:eu-repo/semantics/restrictedAccess | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | COVID 19 | spa |
| dc.subject | Lesión renal aguda | spa |
| dc.subject | Fragilidad | spa |
| dc.subject | COVID-19 | eng |
| dc.subject | Acute kidney injury | eng |
| dc.subject | Frailty | eng |
| dc.title | Impacto de la fragilidad y la carga viral en la lesión renal aguda en los pacientes afectados por Covid-19 | spa |
| dc.type.driver | info:eu-repo/semantics/other | spa |
| dc.type.spa | Otros | spa |
| dcterms.references | World Heal th Organization. New Coronavirus . China; 2020 | eng |
| dcterms.references | Gorbalenya AE, Baker SC, Baric RS, et al. The species and its viruses—a stateme n t of the Coronavi rus Study Group. Biorxiv . 2020:1-15 | eng |
| dcterms.references | Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavi rus- infected pneumoni a in Wuhan, China. JAMA . 2020;323(11):1061- 1069 | eng |
| dcterms.references | Naicke r S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The Novel coronavirus 2019 epidemic and kidneys. Kidney Int . 2020;97(5):824- 828. doi: 10.1016/j.kint.2020.03.001 . | eng |
| dcterms.references | Su H, Yang M, Wan C, et al. Renal histopa thological analysis of 26 postmortem findings of patient s with COVID-19 in China. Kidney Int . 2020;98(1):219- 227. doi: 10.1016/j.kint.2020.04.003 . | eng |
| dcterms.references | Gaba r r e P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L. Acute kidney injury in critically ill patient s with COVID-19. Intensiv e Care Med . 2020;46(7):1339- 1348. doi: 10.1007/ s0013 4- 020- 06153- 9 . | eng |
| dcterms.references | Cheng Y, Luo R, Wang K, et al. Kidney Impai rme nt is associated with in-hospital death of COVID-19 patient s . medRxiv . 2020:1- 21. doi: 10.1101/2020.02.18.20023 2 4 2 . | eng |
| dcterms.references | Sang L, Chen S, Zheng X, et al. The incidenc e, risk factors and prognosis of acut e kidney injury in sever e and critically ill patients with COVID-19 in Mainland China: a ret rospe c t ive study. Research Square; 2020. | eng |
| dcterms.references | Shafi ST. Covid- 19 and acute kidney injury: recent updates . Pak J Kidney Dis . 2020;4(2):225- 227. | eng |
| dcterms.references | Corman V , Landt O, Kaiser M , Molenkamp R , Meijer A, Chu D , Bleicker T, Brünink S, Schneide r J, Schmidt ML, Mulders D, Haagma ns B, van der Veer B , van den Brink S, Wijsman L, Goder ski G, Romet t e JL , Ellis J , Zambon M , Peiris M, Goossens H, Reusken C , Koopmans M, Drosten C. Detection of 2019 novel coronavi rus (2019- nCoV) by real- time RT-PCR. EURO Surveill. 2020;25(3):23- 30 doi: 10.2807/1560- 7917.ES.2020.25.3.2000 04 5 . | eng |
| dcterms.references | KDIGO Clinical practic e guideline for acut e kidney injury. Kidney Int Suppl . 2012;2(1):1- 38. | eng |
| dcterms.references | Musso CG, Jauregui JR, Macías Núñez JF. Frailty phenotype and chronic kidney disea se: a review of the litera tur e . Int Urol Nephrol . 2015;47(11):1801- 1807. | eng |
| dcterms.references | King-Vela E, Muñoz J, Rico- Font alvo J, et al. Acute kidney injury in Colombian patient s with COVID-19 who received kidney support therapy with genius® 90 technology. J Clin Nephrol . 2020;4(3):056- 060. | eng |
| dcterms.references | Gondo- an K, Temel S, Baran Ketencio- lu B, Rabah B, Tutar N, Sungur M. Acute kidney injury in SARS-CoV-2 infected critically ill Patient sTurki sh. J Nephrol . 2020;29:185- 189. | eng |
| dcterms.references | Chan L, Chaudha ry K, Saha A, et al. on behalf of the Mount Sinai COVID Informa t ics Cente r (MSCIC). AKI in hospitalized patient s with COVID-19. JASN Septemb e r 2020. doi: 10.1681/ASN.202005 0 6 1 5 | eng |
| dcterms.references | Cheng Y, Luo R, Wang K, et al. Kidney diseas e is associat ed with in-hospital death of patient s with COVID-19. Kidney Int . 2020;97(5):829- 838 | eng |
| dcterms.references | Meijer s B, Hilbrands LB. The clinical characteristics of coronavi rus- associat ed nephropa t hy. Nephrol Dial Transplant . 2020;35(8):1279- 1281. 18. Shafi ST. Covid- 19 and acute kidney injury: recent updates . PJKD. 2020;4(2):225- 227 | eng |
| dcterms.references | Molina- Barraga n AM, Pardo E, Galichon P, et al. SARS-COV2 renal impairment in critical care: A ret rospe c t ive study of 42 cases—Kid COVID Stud y . Resea r ch Squa r e . doi: 10.21203/ r s .3. r s- 64088/v1 | eng |
| dcterms.references | Golmai P, Larsen, DeVita M, et al. Histopa thologic and ultrastructural findings in postmor t em kidney biopsy material in 12 patient s with AKI and COVID-19. JASN . 2020;31:1944- 1947. doi: 10.1681/ASN.202005 0 6 8 3 | eng |
| dcterms.references | Batlle D, Soler MJ, Sparks MA, et al. and on behalf of the COVID. 19 and ACE2 in cardiovascul a r , lung, and Kidney Working Group. Acute kidney injury in COVID19: emerging evidence of a distinct pathophysiology. J Am Soc Nephrol . 2020;31(7):1380- 1383. doi: 10.1681/ASN.202004 0 4 1 9 . | eng |
| dcterms.references | Sise ME, Bagge t t MV, Shepa rd JO, Stevens JS, Rhee EP. Case 17- 2020: A 68- year- old man with Covid- 19 and kidney acute injury. N Engl J Med . 2020;382(22):2147- 2156. | eng |
| dcterms.references | Su H, Yang M, Wan C, et al. Renal histopa thological analysis of 26 postmortem findings of patient s with COVID-19 in China. Kidney Int . 2020;98(1):219- 227. doi: 10.1016/j.kint.2020.04.003 . | eng |
| dcterms.references | Naicke r S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The Novel coronavi rus 2019 epidemic and kidneys. Kidney Int . 2020;97(5):824- 828 | eng |
| dcterms.references | Hernand e z- Arroyo CF, Varghe s e V, Mohamed MMB, Velez JCQ. Urinary sediment microscopy in acute kidney injury associated with COVID-19. Kidney360 . 2020;1(8):819- 823. doi: 10.34067/KID.000335 20 2 0 | eng |
| dcterms.references | Pujada s E, Chaudhry F, McBride R, et al. SARS-CoV-2 viral load predict s COVID-19 mor tality. Lancet . 2020;8(9):e70. | eng |
| dcterms.references | Khan S, Chen L , Yang CR, et al. Does SARS-CoV-2 Infect the Kidney? JASN.2020;31: 1-3 doi: https://doi.org/10.1681/ASN.2020081229 | eng |
| dcterms.references | Braun F, Hube r T, Puelles V. Proximal tubula r dysfunction in patient s with COVID-19: what have we learnt so far? Kidney Int . 2020 Nov; 98(5): 1092–1094. doi: 10.1016/j.kint.2020.09.002 | eng |
| dcterms.references | González C, Yama E, Yomayus a N, et al. [Colombian Consens us of Exper t s on Evidenc e- Informed Recomme n d a t ions for the Prevent ion, Diagnosis and Manageme n t of SARS-CoV-2 / COVID-19 Acute Kidney Injury]. Rev. Colomb. Nefrol. [Interne t ] . 2 de junio de 2020 [citado 1 de noviembr e de 2020];7(Supl.2). https:// revis t an ef rologia.org/index.php/ r cn/ a r t icle/view/473 | eng |
| dcterms.references | Lee J, Silberzweig J, Akchurin O, et al. Characteristics of Acute Kidney Injury in Hospitalized COVID-19 Patients in an Urban Academic Medical Center. CJASN. 2021;16:1-3 doi: https://doi.org/10.2215/CJN.07440520 | eng |
| dcterms.references | Jingyuan Liu, Yao Liu, Pan Xiang et al. Neut rophil- to-Lymphocyte Ratio Predicts Sever e Illness Patient s with 2019 Novel Coronavirus in the Early Stage. https://doi.org/10.1101/2020.02.10.2002 1 5 8 4 | eng |
| dcterms.references | Fei Zhou, Ting Yu, Ronghui Du et al. Clinical cour se and risk factors for mort ality of adult inpatients with COVID-19 in Wuhan, China: a ret rospective cohort Study. Lancet 2020; 395: 1054- 62 | eng |
| dcterms.references | Qiurong Ruan , Kun Yang, Wenxia Wang et al. Clinical predictor s of mortality due to COVID-19 based on an analysis of data of 150 patient s from Wuhan, China. Intensive Care Med 2020. Intensive Care Med (2020) 46:846–848 https://doi.org/10.1007/ s001 34- 020- 05991- x | eng |
| dcterms.references | Páramo Fernánd e z J. Coagula ción, Dímero D y COVID-19. Sociedad Español a de Trombosis y Hemos t a si a (SETH) https://www. s e t h. e s /index.php/noticia s/not icias /not icias- de- la- seth/1588- coagula cion- dimero- d-y-covid- 19.html | spa |
| dcterms.references | Pérez G. Coronavi rus . Impacto cardiovascular . Sociedad Interamericana de Cardiología. http://www. sia c a rdio.com/noved ad e s / covid- 19/coronavi rus- ysuimpacto- cardiovascul a r / | spa |
| dcterms.references | Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Bondi- Zoccai G,Brown TS, Nigoghos si an CD, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ, Stone GW, Krumholz HM, Parikh SA, Cardiovascul a r Conside r a t ions for Patient s , Health Care Worker s , and Heal th Systems During the Coronavi rus Disease 2019 (COVID-19) Pandemi c, Journal of the American College of Cardiology (2020), doi:https://doi.org/10.1016/j.jacc.2020.03.031. | eng |
| dcterms.references | Qin C, Zhou L, Hu Z et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clint Infect Dis 2020. https://doi.org/10.1093/ cid/ciaa | eng |
| dcterms.references | Meht a P, McAuley DF, Brown M, Sanchez E, Tatte r s all RS, Manson JJ. COVID-19: conside r cytokine storm syndrome s and immunosupp r e s s ion. Lancet 2020. https://doi.org/10.1016/S0140- 6736(20)30628- 0 | eng |
| oaire.version | info:eu-repo/semantics/acceptedVersion | spa |
| sb.programa | Especialización en Nefrología | spa |
| sb.sede | Sede Barranquilla | spa |